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26% of the patients randomised to conservative treatment
later crossed over and had surgery for neurological deterio-
ration. Because they were (by definition) surgical candidates,
earlier surgery in this group may have changed the overall
results. So, while the STICH study shows that surgical evac-
uation should not be routinely applied, early neurosurgical
consultation is still an important emergency action.
The other important recently published study of ICH is a
randomised trial of recombinant factor VII [4]. This prelimi-
nary study tested various doses of factor VII vs. placebo
within 4 h of symptom onset in nearly 400 patients with ICH.
There are therapeutic benefits, but as one might anticipate,
thromboembolic events (myocardial infarction and stroke)
were more common in the treatment group than the placebo
group (though not statistically significant – 7% vs. 2%,
p=0.12). This drug is very expensive. Emergency physicians
ought to be aware of this treatment because some experts
have begun to use it off-label. Phase III study results will
soon be available but as of January 2007 this treatment is not
FDA-approved in the USA for this indication.
Blood pressure control is another key issue for emer-
gency physicians. Here, there is a paucity of quality data.
While the AHA recommends not treating blood pressure of
<180/105 mmHg, decisions must be individualised. It is the
cerebral perfusion pressure and the underlying vascular
lesion that clinicians must consider. Blind adherence to a
specific target blood pressure in all patients may do more
harm than good. The PROGRESS trial referred to in the clos-
ing paragraph of Marietta’s review refers to secondary stroke
prevention using long-term antihypertensives [5]. This
should not be misinterpreted as proof that acutely lowering
blood pressure improves outcomes in ICH patients.
Marietta’s superb review of this important and common
problem is well worth reading. Applied intelligently, airway
management, blood pressure control, use of pro-thrombotic
agents and neurosurgical consultation in the emergency
department can have a favourable significant impact on long-
term outcomes of patients with ICH.
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As newer time-dependent therapies become available for
patients with cerebrovascular diseases, emergency physi-
cians must become more comfortable in the diagnosis and
management for these patients. This is true of both
ischaemic and haemorrhagic stroke.
As Marietta and colleagues point out in their excellent
review on intracerebral haemorrhage (ICH) [1], airway con-
sideration is always the priority, not only to protect the air-
way, but also to prevent secondary brain injury from hypox-
ia and hypercarbia. When intubating, many emergency
physicians pre-treat with lidocaine and fentanyl, and some
administer a defasciculating dose of vecuronium, all to pre-
vent transient increases in intracranial pressure. While the
supporting data for these interventions are weak, there are
minimal associated risks.
Marietta’s review focuses on the most common causes of
ICH – hypertension, cerebral amyloid angiopathy and oral
anticoagulant therapy; however, some causes such as
aneurysms and arteriovenous malformations can present in
an identical fashion, and require definitive therapy.
Therefore, cerebrovascular imaging should be considered in
selected ICH patients, particularly in young, normotensive
ones who are surgical candidates [2].
The current review also discusses the STICH study [3].
This investigation has two important limitations. Firstly, it
did not test the hypothesis that very early surgery helps;
many patients in the surgical arm did not have their proce-
dure in the first 12 h from onset of symptoms. Secondly,
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